Clobetasol Propionate Ophthalmic Nanoemulsion, 0.05% in the Treatment of Inflammation After Cataract Surgery in Pediatric Population
Condition: Cataracts Infantile Interventions: Drug: Clobetasol Propionate; Drug: Prednisolone acetate ophthalmic suspension, 1% Sponsor: Salvat Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cataract Removal | Cataracts | Clobetasol | Nanotechnology | Opthalmology | Pediatrics | Prednisolone | Research